Authors:
KLUWE L
MACCOLLIN M
TATAGIBA M
THOMAS S
HAZIM W
HAASE W
MAUTNER VF
Citation: L. Kluwe et al., PHENOTYPIC VARIABILITY ASSOCIATED WITH 14 SPLICE-SITE MUTATIONS IN THE NF2 GENE, American journal of medical genetics, 77(3), 1998, pp. 228-233
Authors:
LANE H
PERKELL J
WOZNIAK J
MANZELLA J
GUIOD P
MATTHIES M
MACCOLLIN M
VICK J
Citation: H. Lane et al., THE EFFECT OF CHANGES IN HEARING STATUS ON SPEECH SOUND LEVEL AND SPEECH BREATHING - A STUDY CONDUCTED WITH COCHLEAR IMPLANT USERS AND NF-2PATIENTS, The Journal of the Acoustical Society of America, 104(5), 1998, pp. 3059-3069
Authors:
JACOBY LB
JONES D
DAVIS K
KRONN D
SHORT MP
GUSELLA J
MACCOLLIN M
Citation: Lb. Jacoby et al., MOLECULAR ANALYSIS OF THE NF2 TUMOR-SUPPRESSOR GENE IN SCHWANNOMATOSIS, American journal of human genetics, 61(6), 1997, pp. 1293-1302
Authors:
MACCOLLIN M
BRAVERMAN N
VISKOCHIL D
RUTTLEDGE M
DAVIS K
OJEMANN R
GUSELLA J
PARRY DM
Citation: M. Maccollin et al., A POINT MUTATION ASSOCIATED WITH A SEVERE PHENOTYPE OF NEUROFIBROMATOSIS-2, Annals of neurology, 40(3), 1996, pp. 440-445
Authors:
PETERFREUND RA
MACCOLLIN M
GUSELLA J
FINK JS
Citation: Ra. Peterfreund et al., CHARACTERIZATION AND EXPRESSION OF THE HUMAN A2A ADENOSINE RECEPTOR GENE, Journal of neurochemistry, 66(1), 1996, pp. 362-368
Authors:
RUTTLEDGE MH
ANDERMANN AA
PHELAN CM
CLAUDIO JO
HAN FY
CHRETIEN N
RANGARATNAM S
MACCOLLIN M
SHORT P
PARRY D
MICHELS V
RICCARDI VM
WEKSBERG R
KITAMURA K
BRADBURN JM
HALL BD
PROPPING P
ROULEAU GA
Citation: Mh. Ruttledge et al., TYPE OF MUTATION IN THE NEUROFIBROMATOSIS TYPE-2 GENE (NF2) FREQUENTLY DETERMINES SEVERITY OF DISEASE, American journal of human genetics, 59(2), 1996, pp. 331-342
Authors:
HARSH GR
MACCOLLIN M
MCKENNA MJ
NADOL JB
OJEMANN R
SHORT MP
Citation: Gr. Harsh et al., MOLECULAR-GENETIC SCREENING FOR CHILDREN AT RISK OF NEUROFIBROMATOSIS.2., Archives of otolaryngology, head & neck surgery, 121(5), 1995, pp. 590-591
Citation: M. Maccollin, CNS YOUNG INVESTIGATOR AWARD LECTURE - MOLECULAR ANALYSIS OF THE NEUROFIBROMATOSIS-2 TUMOR-SUPPRESSOR, Brain & development, 17(4), 1995, pp. 231-238
Authors:
MACCOLLIN M
BRAVERMAN N
SIFFERT J
HOFMAN K
GUSELLA J
PARRY D
Citation: M. Maccollin et al., IDENTICAL INACTIVATING MUTATION IN 3 CHILDREN WITH NEUROFIBROMATOSIS TYPE-2, Annals of neurology, 38(3), 1995, pp. 554-554
Authors:
PARRY DM
MACCOLLIN M
PULASKI K
ELDRIDGE R
FGUSELLA J
Citation: Dm. Parry et al., SEARCH FOR CORRELATIONS BETWEEN CLINICAL SUBTYPES AND GENOTYPES IN NEUROFIBROMATOSIS-2 (NF2), Neurology, 45(4), 1995, pp. 440-441
Citation: C. Bove et al., ADVISABILITY OF TESTING CHILDREN AND ADOLESCENTS PRESYMTOMATICALLY FOR NFII - FAMILIES AND NURSES PERCEPTIONS, American journal of human genetics, 57(4), 1995, pp. 2017-2017
Authors:
HAASE VH
TROFATTER JA
MACCOLLIN M
TARTTELIN E
GUSELLA JF
RAMESH V
Citation: Vh. Haase et al., THE MURINE NF2 HOMOLOG ENCODES A HIGHLY CONSERVED MERLIN PROTEIN WITHALTERNATIVE FORMS, Human molecular genetics, 3(3), 1994, pp. 407-411